CytomX Therapeutics, Inc. earnings per share and revenue

CTMX earnings per share for the last quarter are 0.02 USD whereas the estimation was -0.05 USD which accounts for 141.42% surprise. Company revenue for the same period amounts to 26.61 M USD despite the estimated figure of 19.60 M USD. Estimated earnings per share for the next quarter are -0.08 USD, and revenue is expected to reach 19.93 M USD. Also watch annual changes over time to get a bigger picture of CTMX earnings per share and revenue dynamics.